Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
about
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@ast
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@en
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure.
@nl
type
label
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@ast
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@en
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure.
@nl
prefLabel
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@ast
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@en
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure.
@nl
P2093
P2860
P356
P1476
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
@en
P2093
Irmina Urbanek
Iwona Cygankiewicz
Krzysztof Kaczmarek
P2860
P356
10.2147/DHPS.S43275
P407
P577
2014-04-28T00:00:00Z